Integrated Analysis of Single-cell RNA-seq and Bulk RNA-seq Unravels the Heterogeneity of Cancer-associated Fibroblasts in TNBC

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2023 Nov 14

PMID 37963845

Authors

Xiaoqing Wu

Wenping Lu

Weixuan Zhang

Dongni Zhang

Heting Mei

Mengfan Zhang

Yongjia Cui

Zhili Zhuo

Affiliations

Soon will be listed here.

Abstract

Background: The treatment of triple-negative breast cancer (TNBC) is one of the main focuses and key difficulties because of its heterogeneity, and the source of this heterogeneity is unclear.

Methods: Single-cell RNA (scRNA) and transcriptomics data of TNBC and normal breast samples were retrieved from Gene Expression Omnibus (GEO) database and TCGA-BRCA database. These cells were clustered using the t-SNE and UMAP method, and the marker genes for each cluster were found. We annotated the clusters using the published literature, CellMarker database and "SingleR" R package.

Results: A total of 1535 cells and 21785 genes from 6 TNBC patients and 2068 cells and 15868 genes from 3 normal breast tissues were used for downstream analyses. The scRNA data were divided into 14 clusters labeled into 8 cell types, including epithelial cells, immunocytes, CAFs/fibroblasts and etc. In the TNBC samples, CAFs were divided into three clusters and labelled as prCAFs, myCAFs and emCAFs, and the marker genes were DCN, FAP and RGS5, respectively. The prCAF subgroup is functionally characterized by promoting proliferation and multi drug resistance; myCAF subgroup is involved in constituting the extracellular matrix and collagen production, matrix composition and collagen production, and the emCAF functionally characterized by energy metabolism.

Conclusions: TNBC has inter- and intra-tumor heterogeneity, and CAF is one of the sources of this heterogeneity. CD74, SASH3, CD2, TAGAP and CCR7 served as significant marker genes with prognostic and therapeutic value.

Citing Articles

Integrating spatial and single-cell transcriptomes reveals the role of COL1A2(+) MMP1(+/-) cancer-associated fibroblasts in ER-positive breast cancer.

Yu Z, Xu H, Wang S, Li Y, Wang G, Tian Y Cancer Cell Int. 2025; 25(1):82.

PMID: 40055751 PMC: 11887395. DOI: 10.1186/s12935-025-03705-1.

Single-cell assay for transposase-accessible chromatin sequencing of human clear cell renal cell carcinoma.

Lu W, Liu Y, Li J, Huang S, Wen Z, Su C Sci Data. 2025; 12(1):334.

PMID: 40000710 PMC: 11861977. DOI: 10.1038/s41597-025-04666-w.

Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T-cell therapy in solid tumors.

Meng S, Hara T, Miura Y, Ishii H Cancer Sci. 2024; 115(11):3532-3542.

PMID: 39169645 PMC: 11531970. DOI: 10.1111/cas.16285.

Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis.

Chen C, Liu J, Lin X, Xiang A, Ye Q, Guo J Cell Death Discov. 2024; 10(1):189.

PMID: 38649701 PMC: 11035635. DOI: 10.1038/s41420-024-01958-9.

Identification of cuproptosis-related miRNAs in triple-negative breast cancer and analysis of the miRNA-mRNA regulatory network.

Wang Y, Wang J, Jiang J, Zhang W, Sun L, Ge Q Heliyon. 2024; 10(7):e28242.

PMID: 38601669 PMC: 11004712. DOI: 10.1016/j.heliyon.2024.e28242.

References

Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y . Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020; 11(1):5077. PMC: 7545162. DOI: 10.1038/s41467-020-18916-5. View

Musa M . Single-cell analysis on stromal fibroblasts in the microenvironment of solid tumours. Adv Med Sci. 2020; 65(1):163-169. DOI: 10.1016/j.advms.2019.12.001. View

Jahandideh A, Yarizadeh M, Masjedi M, Fatehnejad M, Jahandideh R, Soheili R . Macrophage's role in solid tumors: two edges of a sword. Cancer Cell Int. 2023; 23(1):150. PMC: 10391843. DOI: 10.1186/s12935-023-02999-3. View

Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W . FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. Cancer Res. 2016; 76(14):4124-35. DOI: 10.1158/0008-5472.CAN-15-2973. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Hao Y, Hao S, Andersen-Nissen E, Mauck 3rd W, Zheng S, Butler A . Integrated analysis of multimodal single-cell data. Cell. 2021; 184(13):3573-3587.e29. PMC: 8238499. DOI: 10.1016/j.cell.2021.04.048. View

Ostermann E, Garin-Chesa P, Heider K, Kalat M, Lamche H, Puri C . Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts. Clin Cancer Res. 2008; 14(14):4584-92. DOI: 10.1158/1078-0432.CCR-07-5211. View

Davis R, Blake K, Ma D, Ishak Gabra M, Hernandez G, Phung A . Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing. Nat Cell Biol. 2020; 22(3):310-320. DOI: 10.1038/s41556-020-0477-0. View

Griffin D, Holodick N, Rothstein T . Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J Exp Med. 2011; 208(1):67-80. PMC: 3023138. DOI: 10.1084/jem.20101499. View

10.

Qi J, Yan J, Idrees M, Almutairi S, Rasheed R, Hussein U . Five EMT-Related Gene Signatures Predict Acute Myeloid Leukemia Patient Outcome. Dis Markers. 2022; 2022:7826393. PMC: 9568336. DOI: 10.1155/2022/7826393. View

11.

Hoadley K, Siegel M, Kanchi K, Miller C, Ding L, Zhao W . Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases. PLoS Med. 2016; 13(12):e1002174. PMC: 5140046. DOI: 10.1371/journal.pmed.1002174. View

12.

Fu D, Hu Z, Xu X, Dai X, Liu Z . Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities. Transl Oncol. 2022; 26:101510. PMC: 9486121. DOI: 10.1016/j.tranon.2022.101510. View

13.

Razi S, Haghparast A, Chodari Khameneh S, Sadrabadi A, Aziziyan F, Bakhtiyari M . The role of tumor microenvironment on cancer stem cell fate in solid tumors. Cell Commun Signal. 2023; 21(1):143. PMC: 10273768. DOI: 10.1186/s12964-023-01129-w. View

14.

Bartoschek M, Oskolkov N, Bocci M, Lovrot J, Larsson C, Sommarin M . Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018; 9(1):5150. PMC: 6279758. DOI: 10.1038/s41467-018-07582-3. View

15.

Hofheinz R, Al-Batran S, Hartmann F, Hartung G, Jager D, Renner C . Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie. 2003; 26(1):44-8. DOI: 10.1159/000069863. View

16.

Biffi G, Oni T, Spielman B, Hao Y, Elyada E, Park Y . IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. Cancer Discov. 2018; 9(2):282-301. PMC: 6368881. DOI: 10.1158/2159-8290.CD-18-0710. View

17.

Fang J, Xiao L, Joo K, Liu Y, Zhang C, Liu S . A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. Int J Cancer. 2015; 138(4):1013-23. PMC: 4715643. DOI: 10.1002/ijc.29831. View

18.

So J, Ohm J, Lipkowitz S, Yang L . Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. Pharmacol Ther. 2022; 237:108253. PMC: 9378710. DOI: 10.1016/j.pharmthera.2022.108253. View

19.

Chen X, Song E . Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2018; 18(2):99-115. DOI: 10.1038/s41573-018-0004-1. View

20.

Spike B, Engle D, Lin J, Cheung S, La J, Wahl G . A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer. Cell Stem Cell. 2012; 10(2):183-97. PMC: 3277444. DOI: 10.1016/j.stem.2011.12.018. View